Evaluation of in vitro and in vivo inhibitory effects of fusidic acid on Babesia and Theileria parasites

Veterinary Parasitology

Volumn 191, Issue 1-2, 2013, Pages 1-10

  Salama, Akram Ahmed ^a,b   AbouLaila, Mahmoud ^a,b   Moussa, Ahmed A ^a,b   Nayel, Mohamed A ^b   El Sify, Ahmed ^b   Terkawi, Mohamad A ^a   Hassan, Hany Y ^b   Yokoyama, Naoaki ^a   Igarashi, Ikuo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Babesia; Fusidic acid; In vitro; In vivo

Indexed keywords

CIPROFLOXACIN; DIMINAZENE ACETURATE; FUSIDIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIA BOVIS; BABESIA CABALLI; BABESIA MICROTI; CONTROLLED STUDY; COW; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; EQUINE PIROPLASMOSIS; FEMALE; GROWTH INHIBITION; HORSE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PIROPLASMOSIS; THEILERIA; THEILERIA EQUI; THEILERIOSIS;

ANIMALS; ANTIPARASITIC AGENTS; BABESIA; BABESIOSIS; CELLS, CULTURED; DIMINAZENE; DRUG SYNERGISM; FEMALE; FUSIDIC ACID; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED BALB C; THEILERIA; THEILERIASIS; TIME FACTORS;

BABESIA; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA MICROTI; BOVINAE; EQUIDAE; MUS; PLASMODIUM FALCIPARUM; THEILERIA; THEILERIA EQUI;

EID: 84869861903     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.08.022     Document Type: Article

References (39)

1. AbouLaila M., Nakamura K., Govind Y., Yokoyama N., Igarashi I. Evaluation of the in vitro growth inhibitory effect of epoxomicin on Babesia parasites. Vet. Parasitol. 2010, 167:19-27.
2. AbouLaila M., Yokoyama N., Igarashi I. Inhibitory effects of (-)-Epigallocatechin-3-gallate from green tea on the growth of Babesia parasites. Parasitology 2010, 137:785-791.
3. AbouLaila M., Sivakumar T., Yokoyama N., Igarashi I. Inhibitory effect of terpene nerolidol on the growth of Babesia parasites. Parasitol. Int. 2010, 59:278-282.
4. AbouLaila M., Munkhjargal T., Sivakumar T., Ueno A., Nakano Y., Yokoyama M., Yoshinary T., Nagano D., Katayama K., EL-Bahy N., Yokoyama N., Igarashi I. Apicoplast targeting antibacterials inhibit the growth of Babesia parasites. Antimicrob. Agents Chemother. 2012, 56:3196-3206.
5. Alanso M.A., Carrasco L. Action of membrane active compounds on mammalian cells. Eur. J. Biochem. 1980, 109:535-540.
6. Aminake M.N., Schoof S., Sologub L., Leubner M., Kirschner M., Arndt H.D., Pradel G. Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast. Antimicrob. Agents Chemother. 2011, 55:1338-1348.
7. Avarzed A., Igarashi I., Kanemaru T., Hirumi K., Omata Y., Saito A. Improved in vitro cultivation of Babesia caballi. J. Vet. Med. Sci. 1997, 59:479-481.
8. Bellahsène A., Forsgren A. Effect of fusidic acid on the immune response in mice. Infect. Immun. 1980, 29:873-878.
9. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., Igarashi I. Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. Am. J. Trop. Med. Hyg. 2003, 68:334-340.
10. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., Igarashi I. Clotrimazole, ketoconazole, and clodinafoppropargyl inhibit the in vitro growth of Babesia bigemina and Babesia bovis (Phylum Apicomplexa). Parasitology 2003, 127:311-315.
11. Bork S., Yokoyama N., Ikehara Y., Kumar S., Sugimoto C., Igarashi I. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob. Agents Chemother. 2004, 48:236-241.
12. Bork S., Okamura M., Matsuo T., Kumar S., Yokoyama N., Igarashi I. Host serum modifies the drug susceptibility of Babesia bovis in vitro. Parasitology 2005, 130:489-492.
13. Brasseur P., Lecoublet S., Kapel N., Vennec L., Ballet J.J. In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob. Agents Chemother. 1998, 42:818-820.
14. Brockelman C.R., Tan-Ariya P. Development of an in vitro microtest to assess drug susceptibility of Babesia bovis and Babesia bigemina. J. Parasitol. 1991, 6:994-997.
15. Contrerast A., Carrascot L. Selective inhibition of protein synthesis in virus-infected mammalian cells. J. Virol. 1979, 29:114-122.
16. El-Khateeb A., Subeki, Takahashi K., Matsuura H., Yamasaki M., Yamato O., Maede Y., Katakura K., Yoshihara T., Nabeta K. Antibabesial ellagic acid rhamnosides from the bark of Elaeocarpus parvifolius. Phytochemistry 2005, 66:2577-2580.
17. Hansson S., Singh R., Gudkov A.T., Liljas A., Logan D.T. Structural insights into fusidic acid resistance and sensitivity in EF-G. J. Mol. Biol. 2005, 348:939-949.
18. Hines S.A., Palmer G.H., Jasmer D.P., McGuire T.C., McElwain T.F. Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family. Mol. Biochem. Parasitol. 1992, 55:85-94.
19. Homer J.M., Aguilar-Delfin I., Telford S.R., Krause P.J., Persing D.H. Babesiosis. Clin. Microbiol. Rev. 2000, 13:451-469.
20. Hotzel I., Suarez C.E., McElwain T.F., Palmer G.H. Genetic variation in the dimorphic regions of RAP-1 genes and rap-1 loci of Babesia bigemina. Mol. Biochem. Parasitol. 1997, 90:479-489.
21. Igarashi I., Avarzed A., Tanaka T., Inoue N., Ito M., Omata Y., Saito A., Suzuki N. Continuous in vitro cultivation of Babesia ovata. J. Protozool. Res. 1994, 4:111-293.
22. Johanson U., Hughes D. Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene 1994, 143:55-59.
23. Johnson R.A., Geoffrey I.M., Goodman C.D. Characterization of two malaria parasite organelle translation elongation factor G proteins: the likely targets of the antimalarial fusidic acid. PLoS ONE 2011, 6:e20633.
24. Kautzky F., Hartinger A., Köhler L.D., Vogt H.-J. In vitro cytotoxicity of antimicrobial agents to human keratinocytes. J. Eur. Acad. Dermatol. Venereol. 1996, 6:159-166.
25. Kuttler K.L. Worldwide impact of babesiosis. Babesiosis of Domestic Animals and Man 1988, 2-22. CRC Press, Inc., Boca Raton, FL. M. Risitic (Ed.).
26. Matsuu A., Yamasaki M., Xuan X., Ikadai H., Hikasa Y. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet. Parasitol. 2008, 157:1-8.
27. Mehlhorn H., Schein E. Redescription of Babesia equi Laveran. 1901 as Theileria equi. Parasitol. Res. 1998, 84:467-475.
28. Moreno V.J., Ricardo R., Goyeneche D., Graham H., Coombs W.J. Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp. Parasitol. 2006, 112:21-30.
29. Mosqueda J., Olvera-Ramirez A., Aguilar-Tipacamu G., Canto G.J. Current advances in detection and treatment of Babesiosis. Curr. Med. Chem. 2012, 19:1504-1518.
30. Nagai A., Yokoyama N., Matsuo T., Bork S., Hirata H., Xuan X., Zhu Y., Claveria G.F., Fujisaki K., Igarashi I. Growth inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures. Antimicrob. Agents Chemother. 2003, 47:800-803.
31. Nakamura K., Yokoyama N., Igarashi I. Cyclindependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro. Parasitology 2007, 134:1347-1353.
32. Rodriguez R.I., Trees A.J. In vitro responsiveness of B. bovis to imidocarb dipropionate and the selection of adapted lines. Vet. Parasitol. 1996, 62:35-41.
33. Roellinghoff M., Rommel M. Babesiosen: biologie, epidemiologie, und schadwirkung. Immunologische undmolekulare Parasitologie 1994, 127-144. GustavFischer Verlag, Jena, Germany, (in German). first ed. M. Roellinghoff, M. Rommel (Eds.).
34. Schein E. Equine babesiosis. Babesiosis of Domestic Animals and Man 1988, 197-209. CRC Press, Boca Raton, FL. M. Rictic (Ed.).
35. Telford S.R., Spielman A. Babesiosis of humans. Topley and Wilson's Microbiology and Microbial Infections 1997, 349-359. Edward Arnold, London. L. Collier, A. Balows, M. Sussman, J.P. Kreier (Eds.).
36. Uilenberg G. International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet. Parasitol. 1995, 57:19-41.
37. Vannier E., Gewurz B.E., Krause P.J. Human babesiosis. Infect. Dis. Clin. N. Am. 2008, 22:469-488.
38. Verbist L. The antimicrobial activity of fusidic acid. Antimicrob. Agents Chemother. 1990, 25:1-5.
39. Zhang L., Ching N.G., Komoda T., Hanada T., Suzuki T., Watanabe K. Antibiotic susceptibility of mammalian mitochondrial translation. FEBS Lett. 2005, 579:6423-6427.